GSK Plc (GSK)

51.53 +0.75 (+1.48%) USD  |  NYSE  |  May 21, 16:00
51.52 -0.01 (-0.02%) Pre-Market: 19:59
More

GSK Research and Development Expense (TTM) : 9.074B for March 31, 2026

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for GSK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
AstraZeneca PLC 14.21B
Johnson & Johnson 14.99B
Eli Lilly & Co. 14.11B
Merck & Co., Inc. 21.57B
Novo Nordisk A/S 8.079B